Streptococcus pneumoniae News and Research

RSS
Streptococcus pneumoniae, or Pneumococcus, is a very common bacterial infection in both industrialized and developing countries. In particular, young children and the elderly represent high-risk populations of developing pneumococcal infections. According to the WHO, the bacterium kills up to one million children under the age of five years each year worldwide. It accounts for many Bacterial Meningitis cases in adults and it is the most common cause of Bacteraemia, Pneumonia, Meningitis and Otitis media in young children.
Exposure to atmospheric dust, high temperatures can increase risk of bacterial meningitis

Exposure to atmospheric dust, high temperatures can increase risk of bacterial meningitis

Study develops new methodology to analyse genetic bases of pathogenic bacteria

Study develops new methodology to analyse genetic bases of pathogenic bacteria

New immunization approach may one day wipe out pneumonia, meningitis

New immunization approach may one day wipe out pneumonia, meningitis

Oxford researchers discover genes that make children more susceptible to bacteraemia

Oxford researchers discover genes that make children more susceptible to bacteraemia

Allergan's sNDA for TEFLARO (ceftaroline fosamil) accepted by FDA

Allergan's sNDA for TEFLARO (ceftaroline fosamil) accepted by FDA

Vaccinations could have significant economic value

Vaccinations could have significant economic value

UM SOM to team up with industry to develop vaccine for preventing deadly bacterial infections

UM SOM to team up with industry to develop vaccine for preventing deadly bacterial infections

Good bacteria can help inhibit growth of S. pneumoniae

Good bacteria can help inhibit growth of S. pneumoniae

Bacteriophage therapy: an alternative to antibiotics? An interview Professor Clokie

Bacteriophage therapy: an alternative to antibiotics? An interview Professor Clokie

Scientists create detailed image of deadly toxin linked to bacterial pneumonia, meningitis, septicaemia

Scientists create detailed image of deadly toxin linked to bacterial pneumonia, meningitis, septicaemia

Paratek initiates Omadacycline phase 3 clinical study in community acquired bacterial pneumonia (CABP)

Paratek initiates Omadacycline phase 3 clinical study in community acquired bacterial pneumonia (CABP)

University of Leicester awarded BBSRC grant to explore three key areas that impact human health

University of Leicester awarded BBSRC grant to explore three key areas that impact human health

FDA permits marketing of first CSF nucleic acid-based test for detection of multiple pathogens

FDA permits marketing of first CSF nucleic acid-based test for detection of multiple pathogens

Allergan's anti-infective portfolio to be highlighted at IDWeek 2015

Allergan's anti-infective portfolio to be highlighted at IDWeek 2015

Pneumococcal and rotavirus vaccines lead to rapid reduction in pediatric hospital burden

Pneumococcal and rotavirus vaccines lead to rapid reduction in pediatric hospital burden

FDA approves Allergan's sNDA to update label for TEFLARO (ceftaroline fosamil)

FDA approves Allergan's sNDA to update label for TEFLARO (ceftaroline fosamil)

Volatile anesthetics may combat viral and bacterial infections in the lung

Volatile anesthetics may combat viral and bacterial infections in the lung

Toxin pneumolysin causes progressive and fatal heart complications

Toxin pneumolysin causes progressive and fatal heart complications

University of Adelaide study reveals how metal cadmium causes toxicity in living cells

University of Adelaide study reveals how metal cadmium causes toxicity in living cells

IU researchers awarded NIH grant to develop new weapon to fight against antibiotic-resistant bacteria

IU researchers awarded NIH grant to develop new weapon to fight against antibiotic-resistant bacteria